Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review
- PMID: 37764771
- PMCID: PMC10534915
- DOI: 10.3390/nu15183987
Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease without pharmacological treatment yet. There is also a lack of specific dietary recommendations and strategies to treat the negative health impacts derived from NAFLD.
Objective: This scoping review aimed to compile dietary patterns, foods, and nutrients to ameliorate NAFLD.
Methods: A literature search was performed through MEDLINE, Scopus, Web of Science, and Google Scholar.
Results: Several guidelines are available through the literature. Hypocaloric Mediterranean diet is the most accepted dietary pattern to tackle NAFLD. Coffee consumption (sugar free) may have a protective effect for NAFLD. Microbiota also plays a role in NAFLD; hence, fibre intake should be guaranteed.
Conclusions: A high-quality diet could improve liver steatosis. Weight loss through hypocaloric diet together with physical activity and limited sugar intake are good strategies for managing NAFLD. Specific dietary recommendations and a Mediterranean plate have been proposed to ameliorate NAFLD.
Keywords: NAFLD; dietary guidelines; dietary recommendations; food; liver steatosis; nutrients.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Relationship between dietary patterns and non-alcoholic fatty liver disease: A systematic review and meta-analysis.J Gastroenterol Hepatol. 2021 Jun;36(6):1470-1478. doi: 10.1111/jgh.15363. Epub 2020 Dec 14. J Gastroenterol Hepatol. 2021. PMID: 33269500
-
Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development.Nutrients. 2021 Apr 24;13(5):1442. doi: 10.3390/nu13051442. Nutrients. 2021. PMID: 33923255 Free PMC article. Review.
-
Role of diet and nutritional management in non-alcoholic fatty liver disease.J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:81-7. doi: 10.1111/jgh.12244. J Gastroenterol Hepatol. 2013. PMID: 24251710
-
[Comparison of the nutritional structure of patients with non-alcoholic fatty liver disease with the most significant nutrition patterns for health].Vopr Pitan. 2024;93(5):125-141. doi: 10.33029/0042-8833-2024-93-5-125-141. Epub 2024 Aug 5. Vopr Pitan. 2024. PMID: 39563156 Russian.
-
Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.J Gastroenterol Hepatol. 2019 Jan;34(1):256-262. doi: 10.1111/jgh.14360. Epub 2018 Jul 16. J Gastroenterol Hepatol. 2019. PMID: 29949199
Cited by
-
YouTube as a Source of Information for Dietary Guidance and Advisory Content in the Management of Non-Alcoholic Fatty Liver Disease.Healthcare (Basel). 2025 Feb 7;13(4):351. doi: 10.3390/healthcare13040351. Healthcare (Basel). 2025. PMID: 39997226 Free PMC article.
-
The role of FGF21 in the interplay between obesity and non-alcoholic fatty liver disease: a narrative review.Rom J Morphol Embryol. 2024 Apr-Jun;65(2):159-172. doi: 10.47162/RJME.65.2.02. Rom J Morphol Embryol. 2024. PMID: 39020530 Free PMC article. Review.
-
Metabolic dysfunction-associated steatotic liver disease and omega-6 polyunsaturated fatty acids: Friends or foes.World J Hepatol. 2025 Mar 27;17(3):102286. doi: 10.4254/wjh.v17.i3.102286. World J Hepatol. 2025. PMID: 40177210 Free PMC article.
-
Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Nutrients. 2024 Dec 31;17(1):143. doi: 10.3390/nu17010143. Nutrients. 2024. PMID: 39796579 Free PMC article. Review.
-
Lifestyle Intervention Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Children with Down Syndrome.Nutrients. 2025 Jul 16;17(14):2331. doi: 10.3390/nu17142331. Nutrients. 2025. PMID: 40732956 Free PMC article.
References
-
- Riazi K., Azhari H., Charette J.H., E Underwood F., A King J., Afshar E.E., Swain M.G., E Congly S., Kaplan G.G., Shaheen A.-A. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2022;7:851–861. doi: 10.1016/S2468-1253(22)00165-0. - DOI - PubMed
-
- Kanwal F., Kramer J.R., Mapakshi S., Natarajan Y., Chayanupatkul M., Richardson P.A., Li L., Desiderio R., Thrift A.P., Asch S.M., et al. Risk of Hepatocellular Cancer in Patients with Non-Alcoholic Fatty Liver Disease. Gastroenterology. 2018;155:1828–1837.e2. doi: 10.1053/j.gastro.2018.08.024. - DOI - PMC - PubMed
-
- GBD 2017 Cirrhosis Collaborators The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:245–266. doi: 10.1016/S2468-1253(19)30349-8. - DOI - PMC - PubMed
-
- Global Burden of Disease Cancer Collaboration. Fitzmaurice C., Abate D., Abbasi N., Abbastabar H., Abd-Allah F., Abdel-Rahman O., Abdelalim A., Abdoli A., Abdollahpour I., et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019;5:1749–1768. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical